
Keywords: AD; Alzheimer's disease; ACSF; artificial cerebro-spinal fluid; CBF; cerebral blood flow; fEPSP; field excitatory postsynaptic potential; GCL; granule cell layer; GLUTs; glucose transporters; 4-HNE; 4-hydroxynonenal; LTP; long-term potentiation; LTD; long